Nektar Therapeutics (NKTR)
Nektar Therapeutics Announces Pricing of $100 Million Public Offering
Nektar Therapeutics Announces Pricing of $100 Million Public Offering
New Form 8-K - ATAI Life Sciences N.V. Filed: 2025-07-01 AccNo: 0001140361-25-024290 Size: 12 MB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Brookdale Senior Living Inc. - Glass Lewis Joins ISS in Raising Concerns About Ortelius Campaign at Brookdale
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
New Form 8-K - Jade Biosciences, Inc. Filed: 2025-07-01 AccNo: 0001193125-25-153427 Size: 172 KB Item 1.01: Entry into a Material Definitive Agreement Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial …
NeoGenomics to Report Second Quarter 2025 Financial Results on July 29, 2025
IQVIA - IQVIA to Announce Second-Quarter 2025 Results on July 22, 2025
Apellis to Receive up to $300 Million from Royalty Purchase Agreement with Sobi for Ex-U.S. Royalties of Aspaveli® (systemic pegcetacoplan)
Verrica Pharmaceuticals Announces Amendment to Collaboration and License Agreement with Torii Pharmaceutical to Launch Global Pivotal Phase 3 Clinical Trial to Study YCANTH® for the Treatment of Common Warts
Nutriband Inc. added to the Russell Microcap® Index, Russell Microcap Growth® Index, Russell 3000E® Index and Russell 3000E Growth® Index
Breckenridge Distillery Unveils Limited-Edition Collectors Art Series Collaboration with Renowned Artist Miles Toland